C. Light Technologies, a Berkeley, CA-based neurotech company, closed a $2.5m seed funding round.
The round, which brings total funding to date to more than $3.25m, was led by Creative Ventures with participation from Yamaha Motor Ventures, Wisconsin Investment Partners, Berkeley Skydeck Fund, the Band of Angels, EGB Capital, Monde Green Ventures, Puck Ventures, and the Vectors Angel Group.
The company intends to use the funds to procure a design and manufacturing firm to turn their working prototype into the finalized commercial product and go through 510(k) FDA clearance.
Led by Dr. Christy K. Sheehy, P.h.D., Co-Founder and CEO, C. Light Technologies is advancing neurological health assessment tools using a 10-second retinal eye-tracking scan for neurological disease. The device is capable of retinal imaging down to the cellular level and tracking movements of the eye as small as 1 micron, measuring microsaccades (small, jerk-like involuntary eye movements). Microsaccades are a type of fixational eye motion that can have predictive value for monitoring neurodegenerative disease progression. In the future, the company plans to fundamentally reshape treatment options for Alzheimer’s, Parkinson’s, ALS, and concussion recovery.
In February, C. Light will also be relocating their corporate offices to Boston, MA.
FinSMEs
03/02/2021